Skip to content
Recall Observatory FDA recall evidence

Drug product

Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.

D-0527-2026

March 13, 2026

Class II

Product summary

Firm
ENDO USA, Inc.
Event
Event 98610
Status
Ongoing
Classification
Class II
Quantity
34,293 vials
Official record key
drug-enforcement:D-0527-2026

Official wording

Reason: Crystallization; identified as Buprenorphine free base

Code information: Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027

Distribution pattern: USA Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Crystallization; identified as Buprenorphine free base